Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
18.03.25
/
50%
€6.81
Target price
18.03.26
€15.58
Performance (%)
55.04%
Price
10:53
€10.56
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Ocular Therapeutix Inc. has seen massive gains of 55.04%. This prediction currently runs until 18.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | 9.552% | 9.552% |
| iShares Core DAX® | -2.597% | -2.126% |
| iShares Nasdaq 100 | -3.356% | 0.640% |
| iShares Nikkei 225® | -4.112% | 0.711% |
| iShares S&P 500 | -2.520% | 0.874% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

